Hematopoietic stem and progenitor cells have been engineered using gold nanoformulations conjugated with CRISPR capable of targeting two distinct genomic loci of therapeutic interest, with potential engraftment in humanized mouse models.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
Journal of Nanobiotechnology Open Access 02 August 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cavazzana, M., Bushman, F. D., Miccio, A., André-Schmutz, I. & Six, E. Nat. Rev. Drug Discov. 18, 447–462 (2019).
Shahbazi, R. et al. Nat. Mater. https://doi.org/10.1038/s41563-019-0385-5 (2019).
Huisman, T. H. J. et al. J. Clin. Invest. 49, 1035–1040 (1970).
Forget, B. G. Ann. N. Y. Acad. Sci. 850, 38–44 (1998).
Liu, R. et al. Cell 86, 367–77 (1996).
Hütter, G. et al. N. Engl. J. Med. 360, 692–698 (2009).
Gupta, R. K. et al. Nature 568, 244–248 (2019).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Asokan, A. CRISPR genome editing in stem cells turns to gold. Nat. Mater. 18, 1038–1039 (2019). https://doi.org/10.1038/s41563-019-0491-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-019-0491-4
This article is cited by
-
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
Journal of Nanobiotechnology (2022)